1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > United States (USA)-Molecular Diagnostics Market, Test Volume Forecast & Companies

United States Molecular Diagnostics Market & Future Forecast to 2018 Overview

Molecular diagnostics is a rapidly–advancing area of research and medicine, with new
technologies and applications being added continuously. Molecular diagnostics is the promising area which can transform disease diagnosis, as diagnosis based on symptoms and use of surrogate markers is replaced by genomic and proteomic analysis. This fundamental shift offers the promise for early disease detection, potentially before symptoms have even occurred.

United States molecular diagnostic market for 2018 is anticipated to more than double from its current value in 2013. In United States molecular diagnostic market, infectious disease controls the highest market share in 2013.

But in terms of test volume food pathogen testing takes the lead pushing infectious disease at number two position.

Molecular oncology tests have emerged as a significant rapidly growing market segment. In the current medical diagnostics market, molecular diagnostics for cancer testing offers one of the brightest areas for growth and innovation. United States constitutes the largest regional market for blood screening and blood products. Molecular diagnostics is also starting to emerge as an important tool for HLA Testing, Food Pathogen Detection Testing and other disease areas.

In companies market share Hologic Inc., Myriad Genetics and Becton Dickinson together these 3 companies control more than 50% market share for 2013. However Becton Dickinson is expected to lose its market share gradually and Roche is expected to take its place by 2018.

United States Molecular Diagnostics Market & Test Volume – Application Segment Analysis (2010 – 2018)

1. Oncology Testing
a) Breast Cancer
b) Colorectal Cancer
c) Prostate Cancer
d) Others

2. Infectious Diseases
a) Virology Testing
b) HPV Testing
c) HAI Testing
d) Critical Care Testing

3. Genetic Testing
4. Blood Screening
5. Food Pathogen Testing
6. Tissue Typing (HLA Testing)

United States Molecular Diagnostics – Company Wise Sales Analysis (2010 – 2018)

1. Roche
2. Abbott
3. Myriad Genetics
4. BioMerieux
5. Qiagen
6. Hologic Inc.
7. Becton Dickinson
8. Siemens
9. Cepheid
10. Others


Renub Research study titled “United States (USA)-Molecular Diagnostics Market, Test Volume Forecast & Companies” provides a comprehensive assessment of the fast–evolving, high–growth Global Molecular Diagnostics Market. This 128 page report with 87 Figures studies the United States Molecular Diagnostics from 4 view points: 1) Market and Forecast 2) Application Wise Market & Forecast 3) Application Wise Test Volume & Forecast 4) Company Wise Molecular Diagnostics Sales & Forecast

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.

Table Of Contents

United States (USA)-Molecular Diagnostics Market, Test Volume Forecast and Companies
Table of Contents

1. Executive Summary

2. United States Molecular Diagnostics Market, Test Volume and Forecast (2010 - 2018)
2.1 United States Molecular Diagnostics Market and Forecast
2.2 United States Molecular Diagnostics Test Volume and Forecast

3. United States Molecular Diagnostics Market and Volume Share (2010 - 2018)
3.1 United States Molecular Diagnostics Market Share and Forecast - Application Wise
3.2 United States Molecular Diagnostics Market Share and Forecast - Company Wise
3.3 United States Molecular Diagnostics Test Volume Share and Forecast - Application Wise

4. United States Molecular Diagnostics Market and Forecast - Application Wise

4.1 Oncology Testing Market (2004 - 2018)
4.1.1 Breast Cancer Testing Market (2004 - 2018)
4.1.2 Colorectal Cancer Testing Market (2004 - 2018)
4.1.3 Prostate Cancer Testing Market (2004 - 2018)
4.1.4 Other Cancer Testing Market (2004 - 2018)

4.2 Infectious Disease Testing Market (2010 - 2018)
4.2.1 Virology Testing Market (2007 - 2018)
4.2.2 HPV Testing Market (2004 - 2018)
4.2.3 HAI Testing Market (2010 - 2018)
4.2.4 Critical Care Testing Market (2010 - 2018)

4.3 Genetic Testing Market (2010 - 2018)
4.4 Blood Screening Market (2006 - 2018)
4.5 Food Pathogen Testing Market (2010 - 2018)
4.6 Tissue Typing (HLA) Testing Market (2008 - 2018)

5. United States Molecular Diagnostics Test Volume - Application Wise

5.1 Oncology Test Volume (2004 - 2018)
5.1.1 Breast Cancer Test Volume (2004 - 2018)
5.1.2 Colorectal Cancer Test Volume (2004 - 2018)
5.1.3 Prostate Cancer Test Volume (2004 - 2018)
5.1.4 Other Cancer Test Volume (2004 - 2018)

5.2 Infectious Disease Test Volume (2010 - 2018)
5.2.1 Virology Test Volume (2007 - 2018)
5.2.2 HPV Test Volume (2004 - 2018)
5.2.3 HAI Test Volume (2010 - 2018)
5.2.4 Critical Care Test Volume (2010 - 2018)

5.3 Genetic Testing Test Volume and Forecast (2010 - 2018)
5.4 Blood Screening Test Volume and Forecast (2006 - 2018)
5.5 Food Pathogen Test Volume and Forecast (2010 - 2018)
5.6 HLA Test Volume and Forecast (2008 - 2018)

6. United States Molecular Diagnostics Market - Company Wise
6.1 Roche - United States Molecular Diagnostic Sales and Forecast
6.2 Abbott Laboratories - United States Molecular Diagnostic Sales and Forecast
6.3 Myriad Genetics - United States Molecular Diagnostic Sales and Forecast
6.4 Biomerieux - United States Molecular Diagnostic Sales and Forecast
6.5 Qiagen - United States Molecular Diagnostic Sales and Forecast
6.6 Hologic Inc. (Acquired Gen-Probe) - United States Molecular Diagnostic Sales and Forecast
6.7 Becton Dickinson - United States Molecular Diagnostic Sales and Forecast
6.8 Siemens - United States Molecular Diagnostic Sales and Forecast
6.9 Cepheid - United States Molecular Diagnostic Sales and Forecast
6.10 Others - United States Molecular Diagnostic Sales and Forecast

7. United States Molecular Diagnostics Market - Driving Factors
7.1 Point A
7.2 Point B
7.3 Point C

8. United States Molecular Diagnostics Market - Challenges
8.1 Point A
8.2 Point B
8.3 Point C

List of Figures:

Figure 2-1: United States - Molecular Diagnostics Market (Million US$), 2010 - 2013
Figure 2-2: United States - Forecast for Molecular Diagnostics Market (Million US$), 2014 - 2018
Figure 2-3: United States - Molecular Diagnostics Test Volume (Million), 2010 - 2013
Figure 2-4: United States - Forecast for Molecular Diagnostics Test Volume (Million), 2014 - 2018

Figure 3-1: United States - Molecular Diagnostics Applications Market Share (Percent), 2010 - 2013
Figure 3-2: United States - Forecast for Molecular Diagnostics Applications Market Share (Percent), 2014 - 2018
Figure 3-3: United States - Company Wise Molecular Diagnostics Market Share (Percent), 2010 - 2013
Figure 3-4: United States - Forecast for Company Wise Molecular Diagnostics Market Share (Percent), 2014 - 2018
Figure 3-5: United States - Molecular Diagnostics Applications Test Volume Share (Percent), 2010 - 2013
Figure 3-6: United States - Forecast for Molecular Diagnostics Applications Test Volume Share (Percent), 2014 - 2018

Figure 4-1: United States - Molecular Diagnostic Oncology Testing Market (Million US$), 2004 - 2013
Figure 4-2: United States - Forecast for Molecular Diagnostic Oncology Testing Market (Million US$), 2014 - 2018
Figure 4-3: United States - Molecular Diagnostic Breast Cancer Testing Market (Million US$), 2004 - 2013
Figure 4-4: United States - Forecast for Molecular Diagnostic Breast Cancer Testing Market (Million US$), 2014 - 2018
Figure 4-5: United States - Molecular Diagnostic Colorectal Cancer Testing Market (Million US$), 2004 - 2013
Figure 4-6: United States - Forecast for Molecular Diagnostic Colorectal Cancer Testing Market (Million US$), 2014 - 2018
Figure 4-7: United States - Molecular Diagnostic Prostate Cancer Testing Market (Million US$), 2004 - 2013
Figure 4-8: United States - Forecast for Molecular Diagnostic Prostate Cancer Testing Market (Million US$), 2014 - 2018
Figure 4-9: United States - Other Molecular Diagnostic Cancer Testing Market (Million US$), 2004 - 2013
Figure 4-10: United States - Forecast for Other Molecular Diagnostic Cancer Testing Market (Million US$), 2014 - 2018
Figure 4-11: United States - Infectious Disease Testing Market (Million US$), 2010 - 2013
Figure 4-12: United States - Forecast for Infectious Disease Testing Market (Million US$), 2014 - 2018
Figure 4-13: United States - Virology Testing Market (Million US$), 2007 - 2018
Figure 4-14: United States - Forecast for Virology Testing Market (Million US$), 2014 - 2018
Figure 4-15: United States - HPV Testing Market (Million US$), 2004 - 2013
Figure 4-16: United States - Forecast for HPV Testing Market (Million US$), 2014 - 2018
Figure 4-17: United States - HAI Testing Market (Million US$), 2010 - 2013
Figure 4-18: United States - Forecast for HAI Testing Market (Million US$), 2014 - 2018
Figure 4-19: United States - Critical Care Testing Market (Million US$), 2010 - 2013
Figure 4-20: United States - Forecast for Critical Care Testing Market (Million US$), 2014 - 2018
Figure 4-21: United States - Genetic Testing Market (Million US$), 2010 - 2013
Figure 4-22: United States - Forecast for Genetic Testing Market (Million US$), 2014 - 2018
Figure 4-23: United States - Blood Screening Market (Million US$), 2006 - 2013
Figure 4-24: United States - Forecast for Blood Screening Market (Million US$), 2014 - 2018
Figure 4-25: United States - Food Pathogen Testing Market (Million US$), 2010 - 2013
Figure 4-26: United States - Forecast for Food Pathogen Testing Market (Million US$), 2014 - 2018
Figure 4-27: United States - HLA Testing Market (Million US$), 2008 - 2013
Figure 4-28: United States - Forecast for HLA Testing Market (Million US$), 2014 - 2018

Figure 5-1: United States - Oncology Test Volume (Million), 2004 - 2013
Figure 5-2: United States - Forecast for Oncology Test Volume (Million), 2014 - 2018
Figure 5-3: United States - Breast Cancer Test Volume (Million), 2004 - 2013
Figure 5-4: United States - Forecast for Breast Cancer Test Volume (Million), 2014 - 2018
Figure 5-5: United States - Colorectal Cancer Test Volume (Million), 2004 - 2013
Figure 5-6: United States - Forecast for Colorectal Cancer Test Volume (Million), 2014 - 2018
Figure 5-7: United States - Prostate Cancer Test Volume (Million), 2004 - 2013
Figure 5-8: United States - Forecast for Prostate Cancer Test Volume (Million), 2014 - 2018
Figure 5-9: United States - Other Cancer Test Volume (Million), 2004 - 2013
Figure 5-10: United States - Forecast for Other Cancer Test Volume (Million), 2014 - 2018
Figure 5-11: United States - Infectious Disease Test Volume (Million), 2010 - 2013
Figure 5-12: United States - Forecast for Infectious Disease Test Volume (Million), 2014 - 2018
Figure 5-13: United States - Virology Test Volume (Million), 2007 - 2018
Figure 5-14: United States - Forecast for Virology Test Volume (Million), 2014 - 2018
Figure 5-15: United States - HPV Test Volume (Million), 2004 - 2013
Figure 5-16: United States - Forecast for HPV Test Volume (Million), 2014 - 2018
Figure 5-17: United States - HAI Test Volume (Million), 2010 - 2013
Figure 5-18: United States - Forecast for HAI Test Volume (Million), 2014 - 2018
Figure 5-19: United States - Critical Care Test Volume (Million), 2010 - 2013
Figure 5-20: United States - Forecast for Critical Care Test Volume (Million), 2014 - 2018
Figure 5-21: United States - Genetic Testing Test Volume (Million), 2010 - 2013
Figure 5-22: United States - Forecast for Genetic Testing Test Volume (Million), 2014 - 2018
Figure 5-23: United States - Blood Screening Test Volume (Million), 2006 - 2013
Figure 5-24: United States - Forecast for Blood Screening Test Volume (Million), 2014 - 2018
Figure 5-25: United States - Food Pathogen Test Volume (Million), 2010 - 2013
Figure 5-26: United States - Forecast for Food Pathogen Test Volume (Million), 2014 - 2018
Figure 5-27: United States - HLA Test Volume (Million), 2008 - 2013
Figure 5-28: United States - Forecast for HLA Test Volume (Million), 2014 - 2018

Figure 6-1: Roche - United States Molecular Diagnostic Sales (Million US$), 2008 - 2013
Figure 6-2: Roche - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
Figure 6-3: Abbott Laboratories - United States Molecular Diagnostic Sales (Million US$), 2010 - 2013
Figure 6-4: Abbott Laboratories - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
Figure 6-5: Myriad Genetics - United States Molecular Diagnostic Sales (Million US$), 2007 - 2013
Figure 6-6: Myriad Genetics - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
Figure 6-7: Biomerieux - United States Molecular Diagnostic Sales (Million US$), 2010 - 2013
Figure 6-8: Biomerieux - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
Figure 6-9: Qiagen - United States Molecular Diagnostic Sales (Million US$), 2010 - 2013
Figure 6-10: Qiagen - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
Figure 6-11: Hologic-Gen-Probe - United States Molecular Diagnostic Sales (Million US$), 2010 - 2013
Figure 6-12: Hologic-Gen-Probe - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
Figure 6-13: Becton Dickinson - United States Molecular Diagnostic Sales (Million US$), 2010 - 2013
Figure 6-14: Becton Dickinson - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
Figure 6-15: Siemens - United States Molecular Diagnostic Sales (Million US$), 2008 - 2013
Figure 6-16: Siemens - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
Figure 6-17: Cepheid - United States Molecular Diagnostic Sales (Million US$), 2010 - 2013
Figure 6-18: Cepheid - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
Figure 6-19: Others - United States Molecular Diagnostic Sales (Million US$), 2010 - 2013
Figure 6-20: Others - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018

Figure 7-1: United States - Investment in the Human Genome Project (Billion US$), 2003, 2012

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

Hematology and Flow Cytometry: A Market Facing Regulatory and Competitive Challenges--Advances in Molecular Diagnostics, IT, and Growing Understanding of Immunologic Forces Regulating Systemic Diseases Will Profoundly Impact the Market

Hematology and Flow Cytometry: A Market Facing Regulatory and Competitive Challenges--Advances in Molecular Diagnostics, IT, and Growing Understanding of Immunologic Forces Regulating Systemic Diseases Will Profoundly Impact the Market

  • $ 15900
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $24,500.  DataPack (test volumes, sales forecasts, supplier shares) $15,900. VPGMarketResearch’s new seven-country report is designed to help current suppliers and potential market ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.